The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Open accessAbstract
Macropinocytosis is a highly conserved endocytic process by which extracellular fluid and its contents are internalized into cells through large, heterogeneous vesicles known as macropinosomes. Oncogenic Ras proteins have been shown to stimulate macropinocytosis but the functional contribution of this uptake mechanism to the transformed phenotype remains unknown. Here we show that Ras-transformed cells use macropinocytosis to transport extracellular protein into the cell. The internalized protein undergoes proteolytic degradation, yielding amino acids including glutamine that can enter central carbon metabolism. Accordingly, the dependence of Ras-transformed cells on free extracellular glutamine for growth can be suppressed by the macropinocytic uptake of protein. Consistent with macropinocytosis representing an important route of nutrient uptake in tumours, its pharmacological inhibition compromises the growth of Ras-transformed pancreatic tumour xenografts. These results identify macropinocytosis as a mechanism by which cancer cells support their unique metabolic needs and point to the possible exploitation of this process in the design of anticancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This especially occurs in nutrient‐deprived states and is regulated by mammalian target of rapamycin complex 1 (mTORC1), controlling protein synthesis.94”
From Hypoalbuminemia: Pathogenesis and Clinical Significance (2019) · cites this paper as [94]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“PDAC cells harboring KRAS∗ rely on increased levels of macropinocytosis for nutrient salvaging to sustain uncontrolled cell growth.14”
From Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers (2025) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“a nutrient salvage process that supports oncogenic growth.14”
From Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers (2025) · cites this paper as [14]
In the citing paper
“PDAC cells utilize macropinocytosis to obtain amino acids through the uptake and degradation of albumin and collagen230–232”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [230]
In the citing paper
“PDAC cells can utilize macropinocytosis to obtain proline from CAF produced collagen230.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [230]
In the citing paper
“Through 13C-labeled isotope labeling experiments we elucidate that exosomes supply amino acids to nutrient-deprived cancer cells in a mechanism similar to macropinocytosis, albeit without the previously described dependence on oncogenic-Kras signaling.”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Commisso et al., 2013
In the citing paper
“Recent studies have shown that macropinocytosis of circulating proteins (especially albumin) could supply amino acids to nutrient-deprived cancer cells (Commisso et al., 2013).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Commisso et al., 2013
In the citing paper
“These results suggested that exosomes themselves might be acting as source of metabolites in a manner similar to macropinocytosis observed recently in Kras expressing pancreatic cancer cells (Commisso et al., 2013).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Commisso et al., 2013
In the citing paper
“expression of mutant Ras or c-Src alleles provides cells with a mechanism that allows them to recover free amino acids through the lysosomal degradation of extracellular proteins”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Commisso et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Self-citationReductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Self-citationComplete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue
Capon, D. J., Chen, E. Y., Levinson, A. D., Seeburg, P. H., & Goeddel, D. V. (1983) · Nature · doi:10.1038/302033a0 · Cited by 997
Induction of Membrane Ruffling and Fluid-Phase Pinocytosis in Quiescent Fibroblasts by ras Proteins
Bar-Sagi, D., & Feramisco, J. R. (1986) · Science · doi:10.1126/science.3090687 · Cited by 734
Self-citationPharmacological Inhibition of Endocytic Pathways: Is It Specific Enough to Be Useful?
Ivanov, A. I. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-178-9_2 · Cited by 615
Oncogenic K‐Ras decouples glucose and glutamine metabolism to support cancer cell growth
Gaglio, D., Metallo, C. M., Gameiro, P. A., Hiller, K., Danna, L. S., Balestrieri, C., Alberghina, L., Stephanopoulos, G., & Chiaradonna, F. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.56 · Cited by 492
Self-citationGLUTAMINE METABOLISM IN LYMPHOCYTES: ITS BIOCHEMICAL, PHYSIOLOGICAL AND CLINICAL IMPORTANCE
Newsholme, E. A., Crabtree, B., & Ardawi, M. S. M. (1985) · Quarterly Journal of Experimental Physiology · doi:10.1113/expphysiol.1985.sp002935 · Cited by 465
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,002
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
Kumar, M. A., Baba, S. K., Khan, I. R., Khan, M. S., Husain, F. M., Ahmad, S., Haris, M., Singh, M., Akil, A. A., Macha, M. A., et al. (2025) · MedComm · doi:10.1002/mco2.70120 · Cited by 52
Nab-paclitaxel: A flattering facelift
Viúdez, A., Ramírez, N., Hernández-García, I., Carvalho, F. L. F., Vera, R., & Hidalgo, M. M. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.06.001 · Cited by 44
Konstantakou, E. G., Voutsinas, G. E., Velentzas, A. D., Bassogianni, A.-S., Paronis, E., Balafas, E., Kostomitsopoulos, N. G., Syrigos, K. N., Anastasiadou, E., & Stravopodis, D. J. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0399-9 · Cited by 44
Delpeut, S., Sisson, G. R., Black, K. M., & Richardson, C. D. (2017) · Journal of Virology · doi:10.1128/jvi.02191-16 · Cited by 44
Kürschner, G., Zhang, Q., Clima, R., Xiao, Y., Busch, J. F., Kilic, E., Jung, K., Berndt, N., Bulik, S., Holzhütter, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22413 · Cited by 45
Buckley, C. M. F., Pots, H., Guého, A., Vines, J. H., Munn, C. J., Phillips, B. A., Gilsbach, B. K., Traynor, D., Nikolaev, A., Soldati, T., et al. (2020) · Current Biology · doi:10.1016/j.cub.2020.05.049 · Cited by 47
Kelly, M. R., Kostyrko, K., Han, K., Mooney, N. A., Jeng, E. E., Spees, K., Dinh, P., Abbott, K. L., Gwinn, D. M., Sweet-Cordero, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1274 · Cited by 43
Targeting Cancer Lysosomes with Good Old Cationic Amphiphilic Drugs
Ellegaard, A., Bach, P. B., & Jäättelä, M. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_56 · Cited by 44
Velez, D. O., Ranamukhaarachchi, S. K., Kumar, A., Modi, R. N., Lim, E. W., Engler, A. J., Metallo, C. M., & Fraley, S. I. (2019) · Integrative Biology · doi:10.1093/intbio/zyz019 · Cited by 45
Self-citationScharenberg, S. G., Dong, W., Ghoochani, A., Nyame, K., Levin‐Konigsberg, R., Krishnan, A. R., Rawat, E. S., Spees, K. K., Bassik, M. C., & Abu-Remaileh, M. (2023) · Science Advances · doi:10.1126/sciadv.adf8966 · Cited by 43
Analyzing Tumor Metabolism In Vivo
Faubert, B., & DeBerardinis, R. J. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-121954 · Cited by 44
Metabolic PET Imaging in Oncology
Sai, K. K. S., Zachar, Z., Bingham, P. M., & Mintz, A. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.17.18112 · Cited by 43
Ménard, L., Floc’h, N., Martin, M. J., & Cross, D. A. E. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2195 · Cited by 43
Yu, L., Teoh, S. T., Ensink, E., Ogrodzinski, M. P., Yang, C., Vazquez, A. I., & Lunt, S. Y. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0205-z · Cited by 44
Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2
Jiang, S., Dong, F.-Y., Da, L., Yang, X., Wang, X., Weng, J.-Y., Feng, L., Zhu, L., Zhang, Y., Zhang, Z., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901237r · Cited by 43
Nikolaou, S., & Machesky, L. M. (2020) · The Journal of Pathology · doi:10.1002/path.5395 · Cited by 45
Larsen, M. T., Mandrup, O. A., Schelde, K. K., Luo, Y., Sørensen, K. D., Dagnæs‐Hansen, F., Cameron, J., Stougaard, M., Steiniche, T., & Howard, K. A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.004 · Cited by 44
Targeting mutated GTPase KRAS in tumor therapies
Fan, G., Lou, L., Song, Z., Zhang, X., & Xiong, X. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113816 · Cited by 46
Takahashi, H., Katsuta, E., Yan, L., Dasgupta, S., & Takabe, K. (2019) · Surgery · doi:10.1016/j.surg.2019.04.011 · Cited by 42
Restall, I. J., Cseh, O., Richards, L. M., Pugh, T. J., Luchman, H. A., & Weiss, S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3923 · Cited by 42
Bioinspired Lipid Nanocarriers for RNA Delivery
Golubovic, A., Tsai, S., & Li, B. (2023) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.2c00073 · Cited by 49
Acid-base transport in pancreatic cancer: Molecular mechanisms and clinical potential
Kong, S. C., Giannuzzo, A., Novak, I., & Pedersen, S. F. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0078 · Cited by 42
CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages
Pacitto, R., Gaeta, I., Swanson, J. A., & Yoshida, S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a0316-141rr · Cited by 39
Pancreatic Cancer: “A Riddle Wrapped in a Mystery inside an Enigma”
Borazanci, E. H., Dang, C. V., Robey, R. W., Bates, S. E., Chabot, J. A., & Hoff, D. D. V. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2070 · Cited by 42
Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers
Pathria, G., & Ronai, Z. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.009 · Cited by 41
NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma
Schild, T., McReynolds, M. R., Shea, C., Low, V., Schaffer, B. E., Asara, J. M., Piskounova, E., Dephoure, N., Rabinowitz, J. D., Gomes, A. P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109238 · Cited by 42
Self-citationSystematic interaction of plasma albumin with the efficacy of chemotherapeutic drugs
Yu, L., Hua, Z., Luo, X., Zhao, T., & Liu, Y. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188655 · Cited by 43
Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions
Yu, Q., Ding, J., Li, S., & Li, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216856 · Cited by 45
Wang, M., Bai, S., & Zhang, Y. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00502g · Cited by 42
Oncogenes strike a balance between cellular growth and homeostasis
Qiu, B., & Simon, M. C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.005 · Cited by 44
Prabhu, A. H., Kant, S., Kesarwani, P., Ahmed, K. A., Forsyth, P. A., Nakano, I., & Chinnaiyan, P. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy185 · Cited by 38
PKM2 promotes reductive glutamine metabolism
Miao, L., Yuanyuan, W., Yuxia, R., Changsen, B., Li, Q., Yanfen, C., Guoguang, Y., & Binghui, L. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0122 · Cited by 42
The endocytic pathways of Dictyostelium discoideum
Vines, J. H., & King, J. (2019) · The International Journal of Developmental Biology · doi:10.1387/ijdb.190236jk · Cited by 36
Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice
Tolani, B., Celli, A., Yao, Y., Tan, Y. Z., Fetter, R. D., Liem, C. R., de Smith, A. J., Vasanthakumar, T., Bisignano, P., Cotton, A. D., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01386-z · Cited by 44
Cancer tissue of origin constrains the growth and metabolism of metastases
Sivanand, S., Gültekin, Y., Winter, P. S., Vermeulen, S. Y., Tchourine, K., Abbott, K. L., Danai, L. V., Gourgue, F., Do, B. T., Crowder, K. D., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01105-9 · Cited by 46
From Concepts to Inhibitors: A Blueprint for Targeting Protein–Protein Interactions
Hong, S. H., Nguyễn, T. T., Ongkingco, J. F., Nazzaro, A., & Arora, P. S. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00046 · Cited by 45
Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics
Qian, Y. (2014) · World Journal of Translational Medicine · doi:10.5528/wjtm.v3.i2.37 · Cited by 41
Alteration of cellular metabolism in cancer cells and its therapeutic prospects
Biswal, B. N., Das, S., Das, B., & Rath, R. (2017) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_60_17 · Cited by 42
Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy
Xie, X., Wu, H., Li, M., Chen, X., Xiao-yun, X., Ni, W., Lu, C., Ni, R., Bao, B., & Xiao, M. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.01.001 · Cited by 41
Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids
Frias, M. A., Mukhopadhyay, S., Lehman, E., Walasek, A., Utter, M., Menon, D., & Foster, D. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010892 · Cited by 42
Kim, S. S., Xu, S., Cui, J., Poddar, S., Le, T. M., Hayrapetyan, H., Li, L., Wu, N., Moore, A. M., Zhou, L., et al. (2019) · Theranostics · doi:10.7150/thno.40195 · Cited by 40
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Patra, S., Elahi, N., Armorer, A., Arunachalam, S., Omala, J., Hamid, I., Ashton, A. W., Joyce, D. A., Jiao, X., & Pestell, R. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700629 · Cited by 43
Macropinocytosis and Cancer: From Tumor Stress to Signaling Pathways
Lambies, G., & Commisso, C. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-94004-1_2 · Cited by 43
Self-citationShen, R., Qin, S., Lv, Y., Liu, D., Ke, Q., Shi, C., Jiang, L., Yang, J., & Zhou, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167060 · Cited by 42
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 39
Macropinocytosis and autophagy crosstalk in nutrient scavenging
Florey, O., & Overholtzer, M. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0154 · Cited by 39
Santiwarangkool, S., Akita, H., Khalil, I. A., Elwakil, M. M. A., Sato, Y., Kusumoto, K., & Harashima, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.009 · Cited by 39
Sabet, N. S., Atashbar, S., Khanlou, E. M., Kahrizi, F., & Salimi, A. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01853-x · Cited by 39
Lu, J., Liu, F., Li, H., Xu, Y., & Sun, S. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c06117 · Cited by 39
The biological role of metabolic reprogramming in pancreatic cancer
Suzuki, T., Otsuka, M., Seimiya, T., Iwata, T., Kishikawa, T., & Koike, K. (2020) · MedComm · doi:10.1002/mco2.37 · Cited by 38
Andersen, H. B., Ialchina, R., Pedersen, S. F., & Czaplińska, D. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10004-4 · Cited by 40
Argitekin, E., Ersoz‐Gulseven, E., Cakan‐Akdogan, G., & Akdoğan, Y. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00363 · Cited by 38
Jiang, G., Chen, H., Huang, J., Song, Q., Chen, Y., Gu, X. Q., Zhen-huan, J., Huang, Y., Lin, Y., Feng, J., et al. (2020) · Advanced Science · doi:10.1002/advs.201903290 · Cited by 38
Polymer nanoparticle-assisted chemotherapy of pancreatic cancer
Su, T., Yang, B., Gao, T., Liu, T., & Li, J. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920915978 · Cited by 38
Rational nanocarrier design towards clinical translation of cancer nanotherapy
Guo, D., Ji, X., & Luo, J. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe35a · Cited by 39
Macropinocytosis: mechanism and targeted therapy in cancers.
Xiao, F., Li, J., Huang, K., Li, X., Xiong, Y., Wu, M., Wu, L., Kuang, W., Lv, S., Wu, L., et al. (2021) · PubMed Central · Cited by 38
FcRn expression in cancer: Mechanistic basis and therapeutic opportunities
Rudnik‐Jansen, I., & Howard, K. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.007 · Cited by 39
Discovery of a Bicyclic Peptidyl Pan-Ras Inhibitor
Buyanova, M. Y., Cai, S., Cooper, J. K., Rhodes, C. A., Salim, H., Sahni, A., Upadhyaya, P., Yang, R., Sarkar, A., Li, N., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01130 · Cited by 40
Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals
Gad, S. F., Park, J., Park, J. E., Fetih, G. N., Tous, S. S., Lee, W., & Yeo, Y. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00783 · Cited by 38
Yan, J., Wang, M., Lv, S., Chen, D., Wu, Z., Zhou, D., Zhang, S., Lv, J., Xu, K., Xu, C., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.055 · Cited by 37
Xu, G., Zhang, Q., Cheng, R., Qu, J., & Li, W. (2025) · Autophagy · doi:10.1080/15548627.2025.2452149 · Cited by 41
Iron Oxide Nanoparticles: An Insight into their Biomedical Applications
Couto, D., Freitas, M., Carvalho, F. D., & Fernandes, E. G. R. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150311151403 · Cited by 37
Targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context
Bi, J., Wu, S., Zhang, W., & Mischel, P. S. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.002 · Cited by 37
Sun, X., Shu, Y., Yan, P., Huang, H., Gao, R.-L., Xu, M., Lu, L., Tian, J., Huang, D., & Zhang, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02904-0 · Cited by 37
Intracellular Transport in Cancer Metabolic Reprogramming
Sneeggen, M., Guadagno, N. A., & Progida, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.597608 · Cited by 39
The metabolic adaptation mechanism of metastatic organotropism
Wang, C., & Luo, D. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00223-4 · Cited by 40
Filić, V., Mijanović, L., Putar, D., Talajić, A., Ćetković, H., & Weber, I. T. (2021) · Cells · doi:10.3390/cells10071592 · Cited by 37
Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
Rai, V., & Agrawal, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228502 · Cited by 36
Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcène, A., & Peulen, O. (2022) · Cancers · doi:10.3390/cancers15010061 · Cited by 38
Cooperative nutrient scavenging is an evolutionary advantage in cancer
Guzelsoy, G., Elorza, S. D., Ros, M., Schachtner, L. T., Hayashi, M., Hobson-Gutierrez, S., Rundstrom, P., Brunner, J. S., Pillai, R., Walkowicz, W. E., et al. (2025) · Nature · doi:10.1038/s41586-025-08588-w · Cited by 37
The Internal Nanostructure of Lipid Nanoparticles Influences Their Diverse Cellular Uptake Pathways
Yap, S. L., Dyett, B., Hobro, A. J., Nguyen, H. T. N., Smith, N. I., Drummond, C. J., Conn, C. E., & Tran, N. L. (2025) · Small · doi:10.1002/smll.202500903 · Cited by 38
Delivery of the CSF-1R to the lumen of macropinosomes promotes its destruction in macrophages
Lou, J., Low-Nam, S. T., Kerkvliet, J. G., & Hoppe, A. D. (2014) · Journal of Cell Science · doi:10.1242/jcs.154393 · Cited by 36
Schink, K. O., Tan, K. W., Spangenberg, H., Martorana, D., Sneeggen, M., Stévenin, V., Enninga, J., Campsteijn, C., Raiborg, C., & Stenmark, H. (2021) · Nature Communications · doi:10.1038/s41467-021-26775-x · Cited by 35
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
Yang, H. S., Zhou, X., Fu, D., Le, C., Wang, J., Zhou, Q., Liu, X., Yuan, Y., Ding, K., & Xiao, Q. (2022) · 癌症：英文版 · doi:10.1002/cac2.12377 · Cited by 38
Selective localization of myosin‐ I proteins in macropinosomes and actin waves
Brzeska, H., Koech, H., Pridham, K. J., Korn, E. D., & Titus, M. A. (2016) · Cytoskeleton · doi:10.1002/cm.21275 · Cited by 35
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs?
Ravera, M., Gabano, E., Tinello, S., Zanellato, I., & Osella, D. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.11.024 · Cited by 36
Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases
Bechard, M. E., Word, A. E., Tran, A. V., Liu, X., Locasale, J. W., & McDonald, O. G. (2018) · Oncogene · doi:10.1038/s41388-018-0346-5 · Cited by 35
Purinergic signaling: Diverse effects and therapeutic potential in cancer
Kaur, J., & Dora, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1058371 · Cited by 36
In Vivo Applications of Dendrimers: A Step toward the Future of Nanoparticle-Mediated Therapeutics
Sztandera, K., Rodríguez-García, J. L., & Ceña, V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040439 · Cited by 38
Shao, D., Li, J., Guan, F., Pan, Y., Xiao, X., Zhang, M., Zhang, H., & Chen, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s73185 · Cited by 35
Chen, Y., Navarrete, M. S., Wang, Y., McClintock, N. C., Sakurai, R., Wang, F., Chen, K. T., Chou, T., Rehan, V. K., Lee, D. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68615-w · Cited by 36
Hall, P. E., Ready, N., Johnston, A. L., Bomalaski, J. S., Venhaus, R. R., Sheaff, M. T., Krug, L. M., & Szlosarek, P. W. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.07.012 · Cited by 35
Wang, C., Ding, S., Wang, S., Shi, Z., Pandey, N. K., Chudal, L., Wang, L., Zhang, Z., Wen, Y., Yao, H., et al. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213529 · Cited by 36
Choi, D., Montermini, L., Meehan, B., Lazaris, A., Metrakos, P., & Rak, J. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12091 · Cited by 30
Tuerhong, A., Xu, J., Shi, S., Tan, Z., Meng, Q., Hua, J., Liu, J., Zhang, B., Wang, W., Yu, X., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03866-y · Cited by 35
Hydroxyapatite-binding albumin nanoclusters for enhancing bone tumor chemotherapy
Kang, N.-W., Lee, J., & Kim, D. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.039 · Cited by 35
Critical role of oncogenic KRAS in pancreatic cancer (Review)
Liu, J., Ji, S., Liang, C., Qin, Y., Jin, K., Liang, D., Xu, W., Shi, S., Zhang, B., Liu, L., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5196 · Cited by 36
Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma
Shen, X., Niu, N., & Xue, J. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0022 · Cited by 39
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Xu, D., Yin, S., & Shu, Y. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00627-5 · Cited by 36
Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
Smith, L. K., Rao, A. D., & McArthur, G. A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.009 · Cited by 36
The role of Her2 and other oncogenes of the PI3K/AKT pathway in mitochondria
Rohlenová, K., Neužil, J., & Rohlena, J. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0130 · Cited by 34
Profiling the Metabolism of Human Cells by Deep 13C Labeling
Grankvist, N., Watrous, J. D., Lagerborg, K. A., Lyutvinskiy, Y., Jain, M., & Nilsson, R. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.09.004 · Cited by 32
Yin, D., Selle, P. H., Moss, A. F., Wang, Y., Dong, X., Xiao, Z., Guo, Y., & Yuan, J. (2019) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-019-0334-9 · Cited by 34
Nutrient availability shapes methionine metabolism in p16/ MTAP -deleted cells
Sanderson, S. M., Mikhael, P. G., Ramesh, V., Dai, Z., & Locasale, J. W. (2019) · Science Advances · doi:10.1126/sciadv.aav7769 · Cited by 36
Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
Liu, X., & Ghosh, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s212861 · Cited by 35
Proteome alterations in pancreatic ductal adenocarcinoma
Pan, S., Brentnall, T. A., & Chen, R. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.020 · Cited by 34
GCN2 adapts protein synthesis to scavenging-dependent growth
Nofal, M., Wang, T., Yang, L., Jankowski, C. S. R., Li, H., Han, S., Parsons, L. R., Frese, A. N., Gitai, Z., Anthony, T. G., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.09.014 · Cited by 38
Self-citationMetabolic reservoir cycles in cancer
Zhang, C., Quinones, A., & Le, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.023 · Cited by 34
Warburg and Krebs and related effects in cancer
Unterlass, J. E., & Curtin, N. J. (2019) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2019.4 · Cited by 35
USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
Hou, P., Ma, X., Yang, Z., Zhang, Q., Wu, C.-J., Li, J., Tan, L., Yao, W., Yan, L., Zhou, X., et al. (2021) · Genes & Development · doi:10.1101/gad.348787.121 · Cited by 35
Metadata
- Authors
- Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., Rabinowitz, J. D., Metallo, C. M., Vander Heiden, M. G., & Bar-Sagi, D.
- Affiliations
- New York University (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- University of California San Diego (US)
- Princeton University (US)
- Hospital of the University of Pennsylvania (US)
- Memorial Sloan Kettering Cancer Center (US)
- ORCID
- Venue
- Nature
- Published
- 2013-05-12
- Volume
- 497
- Issue
- 7451
- Pages
- 633-637
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3810415
- OpenAlex
- W2129917557
- Cited by
- 1,683
- References
- 31
- Citations by year
- 2026: 120 · 2025: 130 · 2024: 130 · 2023: 136 · 2022: 162 · 2021: 186 · 2020: 166 · 2019: 135 · 2018: 129 · 2017: 113 · 2016: 119 · 2015: 79 · 2014: 56 · 2013: 20
- FWCI
- 52.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- National Cancer Institute (R01CA055360, P01CA104838, R01CA105463, P30CA014051, P01CA117969, P30CA016087, R01CA163591)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- macropinocytosis, oncogenic Ras, amino acid supply, glutamine addiction, cancer metabolism, macropinosomes, protein degradation, pancreatic tumours, nutrient uptake, cancer therapy
- MeSH terms
- Amino Acids, Animals, Biological Transport, Carbon, Cell Line, Transformed, Cell Transformation, Neoplastic, Disease Models, Animal, Female, Glutamine, Mice, Nude, Pancreatic Neoplasms, Pinocytosis, Oncogene Protein p21(ras), NIH 3T3 Cells, Cell Line, Tumor, Cell Proliferation, Mice, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
